Tenon Medical executes 1-for-10 reverse stock split effective Nov 2, 2023 to meet Nasdaq minimum bid

Tenon Medical, Inc.

Reverse split ratio 1:10; each 10 pre-split shares become 1 post-split share.
Effective 12:01 a.m. ET on Nov 2, 2023; trading on split-adjusted basis under TNON.
Approved by stockholders at Sep 13, 2023 annual meeting; primary goal is to meet $1.00 minimum closing price for Nasdaq listing.
No fractional shares; fractional amounts rounded up to one whole share; new CUSIP 88066N204.
Vstock Transfer acting as exchange agent; stockholders need not take action; book-entry shares handled automatically.

item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tenon Medical, Inc.: Certificate of Amendment to effect a 1-for-10 reverse stock split (effective 2023-11-02).

Change: charter amendment
Effective: 2023-11-02

Exact text from the filing

filed on November 1, 2023 a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation, of the Company with the Secretary of State of the State of Delaware (the “Certificate of Amendment”) that provides for a 1-for-10 reverse stock split (the “Split”) of its shares of common stock, par value $0.001 per share (the “Common Stock”) that became effective at 12:01 a.m. on November 2, 2023.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-084331

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.